APA aipamena

Pourbagheri-Sigaroodi, A., Safaroghli-Azar, A., Shanaki, M., Yousefi, A., Anjam Najmedini, A., & Bashash, D. (2020). Inhibition of Cyclin-dependent Kinase (CDK) Decreased Survival of NB4 Leukemic Cells: Proposing a p53-Independent Sensitivity of Leukemic Cells to Multi-CDKs Inhibitor AT7519. Iran J Pharm Res.

Chicago Style aipamena

Pourbagheri-Sigaroodi, Atieh, Ava Safaroghli-Azar, Mehrnoosh Shanaki, Amir-Mohammad Yousefi, Ali Anjam Najmedini, and Davood Bashash. "Inhibition of Cyclin-dependent Kinase (CDK) Decreased Survival of NB4 Leukemic Cells: Proposing a P53-Independent Sensitivity of Leukemic Cells to Multi-CDKs Inhibitor AT7519." Iran J Pharm Res 2020.

MLA aipamena

Pourbagheri-Sigaroodi, Atieh, et al. "Inhibition of Cyclin-dependent Kinase (CDK) Decreased Survival of NB4 Leukemic Cells: Proposing a P53-Independent Sensitivity of Leukemic Cells to Multi-CDKs Inhibitor AT7519." Iran J Pharm Res 2020.